-
1Academic Journal
المؤلفون: A. Kravchenko V., N. Sizova V., S. Minaeva V., O. Kozyrev A., F. Nagimova I., O. Efremova S., D. Gusev A., E. Ovsyannikova V., А. Кравченко В., Н. Сизова В., С. Минаева В., О. Козырев А., Ф. Нагимова И., О. Ефремова С., Д. Гусев А., Е. Овсянникова В.
المصدر: Journal Infectology; Том 11, № 1 (2019); 33-40 ; Журнал инфектологии; Том 11, № 1 (2019); 33-40 ; 2072-6732 ; 10.22625/2072-6732-2019-11-1
مصطلحات موضوعية: HIV infection, ART, drug 6НР, ВИЧ-инфекция, АРТ, препарат 6НР
وصف الملف: application/pdf
Relation: https://journal.niidi.ru/jofin/article/view/848/685; Покровский, В.В. Национальные рекомендации по диспансерному наблюдению и лечению больных ВИЧ-инфекцией 2017. (Клинический протокол) / В.В. Покровский [и др.]. // Эпидемиология и инфекционные болезни. Актуальные вопросы. – 2017. – № 6, Приложение. – С. 1–80.; Guidelines for the Clinical Management and Treatment of HIV-infected Adults in Europe (Version 9.0; October, 2017). European AIDS Clinical Society (http://www.europeanaidsclinicalsociety.org).; Кравченко, А.В. Фосфазид : монография / А.В. Кравченко, Г.А. Галегов, В.Г. Канестри. – М.: ИД «МЕДПРАКТИКА-М», 2017. – 208 с.; Хандажинская, А.Л. 5’-фосфонаты АZT: достижения и перспективы в лечении и профилактике ВИЧ-инфекции / А.Л. Хандажинская, Е.А. Широкова // Acta Naturae, 2013; 5(3): 57-65. https://socionet.ru/d/spz:cyberleninka:22839:15529965/ http://cyberleninka.ru/article/n/5-fosfonaty-azt-dostizheniya-i-perspektivy-v-lechenii-i-profilaktikevich-infektsii; Кравченко, А.В. Безопасность и переносимость препарата 6НР у взрослых ВИЧ-инфицированных больных, ранее не получавших АРВТ / А.В. Кравченко [и др.] // ВИЧ-инфекция и иммуносупрессии. – 2015. – № 7(4). – С. 64–73. – http://dx.doi.org/10.22328/2077-9828-2015-7-4-64-73; https://journal.niidi.ru/jofin/article/view/848
-
2Academic Journal
المؤلفون: O. YURIN G., O. EFREMOVA S., О. ЮРИН Г., О. ЕФРЕМОВА С.
المصدر: Meditsinskiy sovet = Medical Council; № 4 (2017); 67-72 ; Медицинский Совет; № 4 (2017); 67-72 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2017-4
مصطلحات موضوعية: HIV infection, clinical guidelines, antiretroviral therapy, antiretroviral drugs, viral load, DHHS, EACS, ВИЧ-инфекция, клинические рекомендации, антиретровирусная терапия, антиретровирусные препараты, вирусная нагрузка
وصف الملف: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/1854/1793; Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med, 2011 Aug 11, 365(6): 493-505. Available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21767103.; Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med, 2010 Jul 15, 363(3): 257-265. Available athttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20647201.; NSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med, 2015, Jul 20. Available at http://www.ncbi.nlm.nih.gov/pubmed/26192873.; TEMPRANO ANRS Study Group, Danel C, Moh R, et al. A trial of early antiretrovirals and isoniazid preventive therapy in africa. N Engl J Med, 2015 Aug 27, 373(9): 808-822. Available at http://www.ncbi.nlm.nih.gov/pubmed/26193126.; Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med, 2009 Apr 30, 360(18): 1815-1826. Available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19339714.; WHO HIV Guidelines. Second Edition. Updated June 2016.; Scaling up antiretroviral therapy in resource-limited settings. Guidelines for a public health approach. Geneva, World Health Organization, 2002. www.who.int/hiv/pub/prev_care/ScalingUp_E.pdf, accessed 15 May 2013.; Vitoria M, Vella S, Ford N. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance and meet the challenges. Current Opinion in HIV and AIDS, 2013, 8: 12– 18.; Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. Geneva, World Health Organization 2006. http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf, accessed 15 May 2013.; Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach. 2006 revision. Geneva, World Health Organization, 2006. http://www.who.int/hiv/pub/mtct/antiretroviral/en/index.html, accessed 15 May 2013.; Antiretroviral therapy of HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2006 revision. Geneva, World Health Organization, 2006. http://www.who.int/hiv/pub/guidelines/paediatric020907. pdf, accessed 15 May 2013.; Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision. Geneva, World Health Organization, 2010. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf, accessed 15 May 2013.; Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach. 2010 revision. Geneva, World Health Organization, 2010. http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf, accessed 15 May 2013.; Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2010 revision. Geneva, World Health Organization, 2010. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf, accessed 15 May 2013.; Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2013 revision. Geneva, World Health Organization, 2013.; EACS Guidelines Version 7.1, November 2014.; EACS Guidelines Version 8,0, October 2015.; EACS Guidelines Version 8.1, October 2016.; DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, 2008.; DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, 2011.; Guide for HIV/AIDS Clinical Care. US department of Health and Human Services/ April 2014, 643 p.; Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents/ Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents — A Working Group of the Office of AIDS Research Advisory Council (OARAC) Downloaded from http://aidsinfo.nih.gov/guidelines on 4/9/2015.; DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, July 2016.; Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Ермак Т.Н., Канестри В.Г., Шахгильдян В.И., Козырина Н.В., Буравцова Е.В., Нарсия Р.С., Покровская А.В., Ефремова О.С., Коннов В.В., Куимова У.А., Попова А.А., Хохлова О.Н., Воронин Е.Е., Афонина Л.Ю., Васильева И.А., Зимина В.Н. Национальные рекомендации по диспансерному наблюдению и лечению больных ВИЧ-инфекцией. Эпидемиология и инфекционные болезни, 2016, 6: 72.; Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med,. 2000, 342: 921-929.; Emery S, Neuhaus JA, Phillips AN et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J. Infect. Dis., 2008, 197(8): 1133-1144.; Severe P, Juste MA, Ambroise A et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N. Engl. J. Med., 2010, 363: 257- 265.; Grinsztejn B, Hosseinipour M, Ribaudo H et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect. Dis., 2014, 14(4): 281-290.; https://www.med-sovet.pro/jour/article/view/1854